Naftzger, Christopher insider trading profile

Arbutus Biopharma Corp (Pre-Merger)

Transaction date 31 Dec 2024

Planned purchase

Price

351.85

Quantity 45,915 +36.1%

Value US$1,624,641

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-02-20	2024-12-31	Arbutus Biopharma Corp (Pre-Merger)	PP Planned purchase	45,915 +36.1% 351.85 US$1,624,641	45,915 +36.1%	351.85	US$1,624,641

Notification date

Transaction date

Company

B/S Transaction type

Nb. shares
Price
Value

Number of shares

Price

Value

Details

2025-02-20

2024-12-31

Arbutus Biopharma Corp (Pre-Merger)

PP Planned purchase

45,915 +36.1%

351.85
US$1,624,641

45,915 +36.1%

351.85

US$1,624,641

Naftzger, Christopher